Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 21:5:110.
doi: 10.1186/1756-0500-5-110.

Immunohistochemical expression of epithelial and stromal immunomodulatory signalling molecules is a prognostic indicator in breast cancer

Elin Richardsen  1 , Rebecca Dale Uglehus, Stein Harald Johnsen, Lill-Tove Busund
Affiliations

Immunohistochemical expression of epithelial and stromal immunomodulatory signalling molecules is a prognostic indicator in breast cancer

Elin Richardsen et al. BMC Res Notes. .

Abstract

Background: The immune system has paradoxical roles during cancer development and the prognostic significance of immune modulating factors is controversial. The aim of this study was to determine the expression of cyclooxygenase 2 (COX-2), transforming growth factor-beta (TGF- beta), interleukin-10 (IL-10) and their prognostic significance in breast cancers. Ki67 was included as a measure of growth fraction of tumor cells.

Methods: On immunohistochemical stained slides from 38 breast cancer patients, we performed digital video analysis of tumor cell areas and adjacent tumor stromal areas from the primary tumors and their corresponding lymph node metastases. COX-2 was recorded as graded staining intensity.

Results: The expression of TGF-beta, IL-10 and Ki67 were recorded in tumor cell areas and adjacent tumor stromal areas. In both primary tumors and metastases, the expression of COX-2 was higher in the tumor stromal areas than in the tumor cell areas (both P < 0.001). High stromal staining intensity in the primary tumors was associated with a 3.9 (95% CI 1.1-14.2) times higher risk of death compared to the low staining group (P = 0.036). The expression of TGF-beta was highest in the tumor cell areas of both primary tumors and metastases (both P < 0.001). High stromal expression of TGF-beta was associated with increased mortality. For IL-10, the stromal expression was highest in the primary tumors (P < 0.001), whereas in the metastases the expression was highest in tumor cell areas (P < 0.001). High IL-10 expression in tumor- and stromal cell areas of primary tumors predicted mortality. Ki67 was higher expressed in tumor stromal areas of the metastases, and in tumor cell areas of the primary tumors (P < 0.001). Ki67 expression in tumor cell areas and stromal areas of the metastases was independently associated with breast cancer mortality.

Conclusions: Stromal expression of COX-2, TGF-beta and Ki67 may facilitate tumor progression in breast cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Expression of COX-2 in primary and metastatic tumors.
Figure 2
Figure 2
Expression of COX-2, TGF-β, IL-10 and Ki67 in tumor cells and stromal cells areas of primary and metastases.
Figure 3
Figure 3
Disease-specific survivals in tumor cell areas and tumor stromal areas of metastatic tumors.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bishop JM. Molecular themes in oncogenesis. Cell. 1991;64:235–248. doi: 10.1016/0092-8674(91)90636-D. - DOI - PubMed
    1. Bissel MJ, Radisky D. Putting tumors in context. Nat Rev Cancer. 2001;1(1):46–54. doi: 10.1038/35094059. - DOI - PMC - PubMed
    1. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nature. 2006;6(5):392–401. - PubMed
    1. Bissel MJ, Barcellos-Hoff MH. The influence of extracellular matrix on gene expression: is struture the message? J Cell Sci. 1987;8:327–343. - PubMed
    1. Kim JB, Stein R, Hare MJ. Tumor-stromal interactions in breast cancer: the role of stroma in tumorigenesis. Tumor Biol. 2005;26(4):173–185. doi: 10.1159/000086950. - DOI - PubMed

Publication types

MeSH terms